-
February 2, 2021 Lupin Announces Appointment of New Independent Director
-
January 28, 2021 Lupin Quarter III FY2021 Results
-
January 25, 2021 Lupin Receives Approval for Sevelamer Carbonate Tablets
-
January 14, 2021 Notice of Q3 FY2021 Board Meeting
-
January 7, 2021 Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets
-
January 6, 2021 Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP
-
December 29, 2020 Lupin launches Mycophenolate Mofetil Tablets USP
-
December 24, 2020 Lupin Receives Tentative Approval for Efinaconazole Topical Solution
-
December 21, 2020 Lupin Receives Approval for Rufinamide Oral Suspension
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications